169 related articles for article (PubMed ID: 12079390)
1. Decreased thermodynamic stability as a crucial factor for familial amyloidotic polyneuropathy.
Niraula TN; Haraoka K; Ando Y; Li H; Yamada H; Akasaka K
J Mol Biol; 2002 Jul; 320(2):333-42. PubMed ID: 12079390
[TBL] [Abstract][Full Text] [Related]
2. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
3. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
4. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
[TBL] [Abstract][Full Text] [Related]
5. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
Morais-de-Sá E; Neto-Silva RM; Pereira PJ; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):512-9. PubMed ID: 16627944
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
[TBL] [Abstract][Full Text] [Related]
7. Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy.
Shinohara Y; Mizuguchi M; Matsubara K; Takeuchi M; Matsuura A; Aoki T; Igarashi K; Nagadome H; Terada Y; Kawano K
Biochemistry; 2003 Dec; 42(51):15053-60. PubMed ID: 14690414
[TBL] [Abstract][Full Text] [Related]
8. Trans-suppression of misfolding in an amyloid disease.
Hammarström P; Schneider F; Kelly JW
Science; 2001 Sep; 293(5539):2459-62. PubMed ID: 11577236
[TBL] [Abstract][Full Text] [Related]
9. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
Zhang Q; Kelly JW
Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.
Miyata M; Sato T; Kugimiya M; Sho M; Nakamura T; Ikemizu S; Chirifu M; Mizuguchi M; Nabeshima Y; Suwa Y; Morioka H; Arimori T; Suico MA; Shuto T; Sako Y; Momohara M; Koga T; Morino-Koga S; Yamagata Y; Kai H
Biochemistry; 2010 Jul; 49(29):6104-14. PubMed ID: 20565072
[TBL] [Abstract][Full Text] [Related]
11. Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.
Ferrão-Gonzales AD; Palmieri L; Valory M; Silva JL; Lashuel H; Kelly JW; Foguel D
J Mol Biol; 2003 May; 328(4):963-74. PubMed ID: 12729768
[TBL] [Abstract][Full Text] [Related]
12. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I
J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
Hou X; Aguilar MI; Small DH
FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
[TBL] [Abstract][Full Text] [Related]
14. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
15. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
16. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
Hammarström P; Sekijima Y; White JT; Wiseman RL; Lim A; Costello CE; Altland K; Garzuly F; Budka H; Kelly JW
Biochemistry; 2003 Jun; 42(22):6656-63. PubMed ID: 12779320
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic stability and denaturation kinetics of a benign natural transthyretin mutant identified in a Danish kindred.
Groenning M; Campos RI; Fagerberg C; Rasmussen AA; Eriksen UH; Powers ET; Hammarström P
Amyloid; 2011 Jun; 18(2):35-46. PubMed ID: 21406045
[TBL] [Abstract][Full Text] [Related]
18. Potential use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathy.
Jono H; Anno T; Motoyama K; Misumi Y; Tasaki M; Oshima T; Mori Y; Mizuguchi M; Ueda M; Shinriki S; Shono M; Obayashi K; Arima H; Ando Y
Amyloid; 2012 Jun; 19 Suppl 1():50-2. PubMed ID: 22620966
[TBL] [Abstract][Full Text] [Related]
19. Different disease-causing mutations in transthyretin trigger the same conformational conversion.
Steward RE; Armen RS; Daggett V
Protein Eng Des Sel; 2008 Mar; 21(3):187-95. PubMed ID: 18276611
[TBL] [Abstract][Full Text] [Related]
20. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
